Gitterman Quoted in Healio on FDA's Compound Drug Regulations
October 6, 2017
Life Sciences and Healthcare Regulatory associate Abraham Gitterman was quoted in a recent Healio article, "Stricter Drug Compounding Regulations Complicate Ophthalmology Care," which assesses how recent legislation and FDA enforcement actions have changed the production process for compound drugs.
